Judge Dismisses Fraud, Misrepresentation Claims Against Plavix Makers



DOCUMENTS
  • Order


TRENTON, N.J. - A New Jersey federal judge has dismissed state law fraud and negligent misrepresentation claims brought against Bristol Meyers Squibb-Co. and Sanofi-Aventis U.S. Inc. in connection with their marketing and sale of the anti-blood clotting drug Plavix. Money v. Bristol-Meyers Squibb Co., et al., No. 3:07-110 (D. N.J.)

In a Dec. 30 order, Judge Freda L. Wolfson of the U.S. District Court for the District of New Jersey ruled that the claims, brought under Oklahoma state law, were inadequately pled.

In 2007, Dale Money, an Oklahoma resident, sued Bristol Myers-Squibb Co., Sanofi-Aventis U.S. L.L.C., Sanofi-Aventis U.S. Inc. and …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's MDL Conference: Depo-Provera and Current MDL Cases

January 29, 2025 - Miami Beach, FL
The Coral Ballroom at the Fontainebleau Miami Beach

MORE DETAILS